- About Breast Cancer
- Community Impact
- Get Involved
OUR IMPACT IN THE MISSION TO END BREAST CANCER
WHERE DO OUR PROCEEDS GO?
Komen-Funded Research Identifies Previously Unknown Gene Mutations Associated with Poor Outcomes in ER+ Breast Cancer
DALLAS – September 4, 2018 – Susan G. Komen®, the world’s largest nonprofit funder of breast cancer research outside the U.S. government, today hailed work….10 most commonly asked questions about life after breast reconstruction surgery
To help ease patients’ minds, the experts at Cancer Treatment Centers of America have compiled a list of answers to commonly asked questions about life….SEE ALL NEWS
TailorRX study shows chemotherapy not needed for some breast cancer patients. Hear from our very own Dr. Sledge. Watch Now!Metastatic Breast Cancer
Komen has invested more than $180 million into research on metastatic breast cancer. Find out what we’ve learned and what we’re investigating. Read more now!